Use of probiotics to reduce infections and death and prevent colonization with extended-spectrum beta-lactamase (ESBL)-producing bacteria among newborn infants in Tanzania (ProRIDE Trial): study protocol for a randomized controlled clinical trial

BACKGROUND: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) has emerged as an urgent global health threat and is by the World Health Organization ranked as priority 1 among pathogens in need of new treatment. Studies have shown high mortality in Tanzanian children with ESBL-E...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwelker, Kanika, Langeland, Nina, Löhr, Iren Høyland, Gidion, Joshua, Manyahi, Joel, Moyo, Sabrina John, Blomberg, Bjørn, Klingenberg, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082054/
https://www.ncbi.nlm.nih.gov/pubmed/33926519
http://dx.doi.org/10.1186/s13063-021-05251-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082054/
https://www.ncbi.nlm.nih.gov/pubmed/33926519
http://dx.doi.org/10.1186/s13063-021-05251-3

Ejemplares similares